Positive Efficacy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Positive Efficacy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Positive Efficacy Today - Breaking & Trending Today

FDA Approves Avacincaptad Pegol for Geographic Atrophy

Published: August 5, 2023

The approval is the second granted to a geographic atrophy drug that targets the complement pathway.

Source: hcplive.com

Related Topics:

United StatesAvacincaptad PegolIapocec David LallyKunzmannk ApellisAstellas PharmaDavid LallyArshadm KhananiDrug AdministrationSierra Eye AssociatesAmerican Society Of Retina SpecialistsApellis PharmaceuticalsIveric BioAmerican SocietyRetina SpecialistsNew England Retina ConsultantsNew TreatmentPegcetacoplan InjectionPublished FebruaryReviewing Retinal Vasculitis CasesPositive EfficacyAvacincaptad Pegol Shows Reduction

Alnylam Announces FDA Approval of Supplemental New Drug Application for OXLUMO® (lumasiran) in Advanced Primary Hyperoxaluria Type 1 - Alnylam Pharmaceuticals (NASDAQ:ALNY) - Press Release

Published: October 7, 2022

- OXLUMO Now Indicated for the Treatment of Primary Hyperoxaluria Type 1 (PH1) to Lower Urinary and Plasma Oxalate Levels in Pediatric and Adult Patie

Source: wiredprnews.com

Related Topics:

United StatesUnited KingdomJorge CapapeyKim HollanderHyperoxaluria FoundationGlobal Rare Disease Lead At Alnylam PharmaceuticalsDrug AdministrationAlnylam Pharmaceuticals IncExchange CommissionAlnylam PharmaceuticalsEuropean Medicines AgencyCommittee For Medicinal Products Human UsePrimary Hyperoxaluria TypeLower UrinaryPlasma Oxalate LevelsAdult PatientsPositive EfficacySafety ResultsSevere Renal ImpairmentIncluding ThoseNew Drug ApplicationVice PresidentGlobal Rare Disease LeadMonth SixExecutive Director